81519 Oncology breast mrna
Also known as: breast cancer mRNA analysis, breast gene expression profiling
Oncology (breast) messenger RNA analysis with gene expression profiling.
In Plain Language
genetic test for breast cancer treatment planning
Clinical Context
Breast tumor mRNA analysis for treatment planning and outcome prediction in breast cancer patients.
RVU Information
CPT 81519 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81519?
CPT 81519 (Oncology breast mrna) is a Pathology & Lab code. Oncology (breast) messenger RNA analysis with gene expression profiling.
Who uses CPT code 81519?
CPT 81519 is used by oncology, breast surgery, molecular pathology. Breast tumor mRNA analysis for treatment planning and outcome prediction in breast cancer patients.
When is CPT 81519 used?
Breast tumor mRNA analysis for treatment planning and outcome prediction in breast cancer patients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.